Estimating the Per-Application Effectiveness of Chlorhexidine Gluconate and Mupirocin in Methicillin-resistant Staphylococcus aureus Decolonization in Intensive Care Units

Eric T. Lofgren, Matthew Mietchen, Christopher Short, Kristen V. Dicks, Rebekah Moehring, Deverick Anderson, for the CDC MIND-Healthcare Program
doi: https://doi.org/10.1101/19012732

Article Information

doi 
https://doi.org/10.1101/19012732
History 
  • November 27, 2019.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Eric T. Lofgren, PhD1,*,
  2. Matthew Mietchen, MPH1,
  3. Christopher Short, PhD1,
  4. Kristen V. Dicks2,
  5. Rebekah Moehring, MD2,
  6. Deverick Anderson, MD2,
  7. for the CDC MIND-Healthcare Program
  1. 1Paul G. Allen School for Global Animal Health, Washington State University, Pullman, WA
  2. 2Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC
  1. ↵*Eric T. Lofgren, Paul G. Allen School for Global Animal Health, Washington State University,240 SE Ott Road, Room 311, Pullman, WA 99164-7090, Email: Eric.Lofgren{at}wsu.edu Phone: (509) 335-4022, Fax: (509) 335-6328
Back to top
Posted November 27, 2019.
Download PDF

Supplementary Material

Data/Code
Email
Estimating the Per-Application Effectiveness of Chlorhexidine Gluconate and Mupirocin in Methicillin-resistant Staphylococcus aureus Decolonization in Intensive Care Units
Eric T. Lofgren, Matthew Mietchen, Christopher Short, Kristen V. Dicks, Rebekah Moehring, Deverick Anderson, for the CDC MIND-Healthcare Program
medRxiv 19012732; doi: https://doi.org/10.1101/19012732
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area